Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Study of Plasmodium Immunotherapy for Advanced Breast Cancers and Advanced Liver Cancers

Next Previous
Trial Profile

Clinical Study of Plasmodium Immunotherapy for Advanced Breast Cancers and Advanced Liver Cancers

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Dec 2018

At a glance

  • Drugs Plasmodium vivax immunotherapy (Primary)
  • Indications Advanced breast cancer; Liver cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors CAS Lamvac Biotech

    • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top